Contacts - BIOFINITY

ROCHESTER, N.Y.-- Clerio Vision , a developer of laser-based vision correction solutions, has acquired Hydrogel Vision Corporation (HVC). Financial details of the transaction were not disclosed. The transaction brings together HVCs long-standing expertise in the manufacturing and distribution of high performance contact lenses with Clerios innovative product pipeline, Clerio said in a statement issued today. HVC, founded in 2002, is best known for its Extreme H2O product line and its multiple ...

>Read More

PLEASANTON, Calif.--In the midst of various efforts to improve its global sustainability efforts, CooperVision Inc. earlier this month published a series of four short videos relating to these sustainability programs. The contact lens company noted it believes providing access to the videos, even in their short form, will resonate more meaningfully with eyecare professionals, partners and others around the world. The companys multiple environmental initiatives are focused on: saving water and ...

>Read More

LAKE ZURICH, Ill.--Services are planned for long-time contact lens and marketing executive, Thomas F. Steiner, 73, who passed away on Dec. 6 after a long illness. Steiner spent 35 years as a visionary marketing executive in the optical industry with Wesley Jessen and CIBA Vision, and later started a business as a marketing consultant. Among his many accomplishments was his involvement in the launch of cosmetic color contact lenses, and the creation of several unique strategic programs for educat...

>Read More

MULLICA HILL, N.J-- OcuMedic, Inc. , the first developer of therapeutic lens for the delivery of drugs for the global ophthalmic market, announced their Contact Drug Delivery System , received a patent by the European Patent Offices, according to a release from the company. The patent will cover all intellectual property of the companys timed-released delivery of drugs directly to the eye through prescription soft-contact lenses. President and CEO of OcuMedic, Inc., Keith D. Ignotz, said, The E...

>Read More

NEW BRUNSWICK, N.J.-- Johnson & Johnson (NYSE: JNJ) on Tuesday reported that its sales rose 10.6 percent to $20.8 billion in the second quarter, due in part to a 19.9 percent sales increase in its pharmaceutical business segment. On an operational basis, the companys overall sales increase was 8.7 percent, and the positive impact of currency was 1.9 percent, according to the announcement. Domestic sales increased 9.4 percent, while international sales rose 11.8 percent, reflecting operational g...

>Read More

FORT WORTH, Texas-- Alcon expects to build upon its 70 years of history in this Texas metro area following its spinoff from parent company Novartis in 2019, the eyecare groups new chief executive officer has said. Fort Worth is where Alcon was born more than 70 years ago, and we look forward to building on our legacy here following the proposed spinoff, chief executive officer David Endicott said in a statement to the Star-Telegram of Fort Worth earlier this week....

>Read More

Product Listings for Contacts - BIOFINITY